Tempest Therapeutics (TPST)

• Market cap: $45.2M
• 1 day: -3.23%
• 5 days: -5.04%
• 1 month: -0.97%
• 3 months: 40.8%
• 6 months: 43.18%
• Year to date: -8.78%
• 1 year: -14.45%
• 5 years: -96.52%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Employees: 5